Article

Relationship between Parathyroid Hormone Levels and Hazards of Fracture, Vascular Events and Death in Stage 3 and 4 Chronic Kidney Disease

2018-11-28

Abstract excerpt

<h4>Background and Objectives:</h4> Chronic kidney disease (CKD) affects ∼20% of older adults and secondary hyperparathyroidism (HPT) is a common condition in these patients. Studies have linked HPT to a greater risk of fractures, vascular events and mortality. However, the optimal parathyroid hormone (PTH) level needed to minimize these events remains uncertain. <h4>Design, setting, participants and measurements...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e872884e-74a7-5b11-b911-eab2a92b34e7
DOI: 10.1101/480848

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Relationship between Parathyroid Hormone Levels and Hazards of Fracture, Vascular Events and Death in Stage 3 and 4 Chronic Kidney DiseaseDOI 10.1101/480848Read

Hyperphosphatemia in Patients with Chronic Kidney Disease (CKD)Semantic proximity Read

CKD-mineral and bone disorder and risk of death and cardiovascular hospitalization in patients on hemodialysis.Semantic proximity Read

Vitamin D Deficiency in Chronic Kidney Disease: Recent Evidence and ControversiesSemantic proximity Read

Effects of genetic variants on serum parathyroid hormone in hyperparathyroidism and end-stage renal disease patients: A systematic review and meta-analysis.Semantic proximity Read

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalizationSemantic proximity Read

Phenotypes of Mineral Bone Disorder in Chronic Kidney Disease in a Dialysis Population.Semantic proximity Read

Clinical Heterogeneity of Calcium–Phosphate Disorders in Advanced CKDSemantic proximity Read

Fibroblast Growth factor 23 and α-Klotho protein are associated with adverse clinical outcomes in non dialysis chronic kidney disease stage 1-5 patientsSemantic proximity Read

Influence of Serum Biochemistry on Bone and Kidney Phenotypes in Subjects With Symptomatic Primary HyperparathyroidismSemantic proximity Read

Expression of Circulating MicroRNAs Linked to Bone Metabolism in Chronic Kidney Disease-Mineral and Bone DisorderSemantic proximity Read

Effectivity and Safety Profile of Tenapanor, a Sodium-Hydrogen Exchanger Isoform 3 Inhibitor, as an Innovative Treatment for Hyperphosphatemia in Chronic Kidney Disease, a Systematic Review of Clinical StudiesSemantic proximity Read

Circulating microRNAs as biomarkers of chronic kidney disease and its association with renal and cardiovascular outcomes in non-dialysis patientsSemantic proximity Read